Abstract
One of the main features of hyperacute renal allograft rejection in presensitised dogs is platelet aggregation within the kidney as detected by light microscopy and renal arterio-venous platelet counts. Graft failure, as determined by reduction and ultimate cessation of renal blood flow and urine production, can be abrogated in the short term by prostacyclin which is the most potent inhibitor of platelet aggregation yet discovered. After 4 h of extracorporeal perfusion, by which time all control kidneys had been rejected, all prostacyclin treated kidneys had normal or above normal blood flow rates, were producing urine and were similar histologically (light microscopy) to 4-hour autografts.
References
May 17, 1979·The New England Journal of Medicine·S Moncada, J R Vane
Feb 2, 1978·Nature·P M BolgerL M Slotkoff
Aug 20, 1970·The New England Journal of Medicine·T E StarzlC G Halgrimson
Feb 1, 1972·Transplantation·A S MacDonaldJ P Merrill
Jan 2, 1969·The New England Journal of Medicine·G M Williams, F Milgrom
Jan 1, 1970·Transplantation·A MacdonaldJ E Murray
Citations
Nov 1, 1981·Prostaglandins·C LeithnerM Schwarz
Dec 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Johannes WaiserHans-Hellmut Neumayer
May 1, 1983·British Heart Journal·J R Vane
Dec 1, 1983·Postgraduate Medical Journal·J R Vane
Jan 1, 1984·Pathology, Research and Practice·A T TrieblingA Gabryelewicz
Aug 1, 1983·Bioscience Reports·J R Vane
Sep 1, 2005·Bioscience Reports·J R Vane
Mar 1, 1983·Kidney International·G FramptonJ S Cameron
Jan 1, 1989·Free Radical Research Communications·C J GreenS Simpkin
Mar 1, 1983·Stroke; a Journal of Cerebral Circulation·S Moncada
May 1, 1982·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S Moncada
May 1, 1982·British Journal of Pharmacology·S Moncada
Apr 1, 1985·Klinische Wochenschrift·M GoerigG Schettler
Aug 1, 1983·British Journal of Pharmacology·J R Vane
Aug 29, 1981·Lancet·M L FoeghG E Schreiner